Page 6 - Nice Green News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Need to know Split model range divided by wheel size: Decoy MX gets a 29in/27.5in mix, while the Decoy 29 uses 29in wheels front and rear. Core 2, 3, and 4 options cover different price points, starting from the entry-level Core 2 with SRAM/RockShox/Shimano parts and topped by the Core 4 with high end carbon frame, Fox Factory suspension, Crankbrothers wheels and Shimano XT drivetrain. New updated motor – the Decoy now gets Shimano’s EP8 unit powered by YT’s own custom 540Wh internal battery Five frame sizes from S-XXL with geometry specific to each version MX version is slacker with a ...

SpineGuard Announces Its Full-Year 2020 Financial Results, First Quarter 2021 Sales and a Flexible Financing of €10M Controlled operating results despite Covid-19 pandemic Cash runway over 36 months Q1-21 OUS growth at 21% Regu SpineGuard Announces Its Full-Year 2020 Financial Results, First Quarter 2021 Sales and a Flexible Financing of €10M SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants announced today its full-year 2020 financial results, as ...

SpineGuard Announces Its Full-Year 2020 Financial Results, First Quarter 2021 Sales and a Flexible Financing of €10M Controlled operating results despite Covid-19 pandemic Cash runway over 36 months Q1-21 OUS growth at 21% Regulatory News: SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants announced today its full-year 2020 financial results, as approved by the Board of Directors on April 8, 2021, its first quarter 2021 sales and a €10M financing in...

Implanet Confirms Offer to Acquire a Majority Stake in Orthopaedic & Spine Development Orthopaedic Spine Development ("OSD") is a manufacturer of implants for spine surgery Acquisition of a majority interest will lead to the creation of a new benchmark player in orthopedic surgery in France and allow the Group to rapidly achieve significant revenue growth. Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it has obtained founding sha...

IMPLANET: Implanet Reports an Improvement in Its 2020 Results Gross margin improvement to 58.2%, versus 56% in 2019 Strengthened cash position Regulatory Nws: IMPLANET (Paris:ALIMP) (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, announces its results for the financial year to December 31, 2020, approved by the Board of Directors on February 16, 2021. " Within the very unique public health context that affected 2020, we generated over 6 million euros in revenue and continued to...